Alitretinoin
An orally- and topically-active naturally-occurring retinoic acid with antineoplastic, chemopreventive, teratogenic, and embryotoxic activities. Alitretinoin binds to and activates nuclear retinoic acid receptors (RAR) and retinoid X receptors (RXR); these activated receptors act as transcription factors, regulating gene expression that results in the inhibition of cell proliferation, induction of cell differentiation, and apoptosis of both normal cells and tumor cells. [ ]
Term info
Alitretinoin
- 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-trans-4-trans-6-cis-8-trans-nonatetraenoic Acid
- 9-Cis-Retinoic Acid
- 9-cRA
- 9-cis Retinoic Acid
- 9-cis retinoic acid
- 9-cis-RA
- 9-cis-Retinoic Acid
- ALITRETINOIN
- ALRT1057
- Alitretinoin
- LGD1057
- Panretin
- Panretyn
- Panrexin
- Retinoicacid-9-cis
NCIT_C63923, NCIT_C128784, NCIT_C157711, NCIT_C157712
A drug being studied for cancer prevention. It belongs to the family of drugs called retinoids.
Topical treatment of cutaneous lesions in patients with AIDS-related Kaposi sarcoma
5300-03-8
CHEBI:50648
C20H28O2
1UA8E65KDZ
Alitretinoin
659772
42147
Alitretinoin
Pharmacologic Substance, Organic Chemical
C0281666
C1574
Term relations
- Retinoic Acid Agent
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Retinoic Acid Receptor Activation
- Chemical_Or_Drug_Has_Physiologic_Effect some Inhibition of Cell Proliferation
- Chemical_Or_Drug_Has_Physiologic_Effect some Apoptosis
- Chemical_Or_Drug_Affects_Gene_Product some Retinoic Acid Receptor
- Chemical_Or_Drug_Has_Physiologic_Effect some Positive Regulation of Cell Differentiation
- Chemical_Or_Drug_Affects_Gene_Product some Retinoid X Receptor